Medicine Matters oncology

Interviews with clinical experts, discussing key issues in oncology.

COVID-19 vaccination in patients with cancer (with Narjust Duma) 03/25/2021

COVID-19 vaccination in patients with cancer (with Narjust Duma) We speak to medical oncologist Narjust Duma, from the University of Wisconsin in the USA, about COVID-19 vaccination in people with cancer, discussing issues such as vaccine timing, side-effects, and key unanswered research questions. /episode/index/show/oncologymedicinematters/id/18468500

Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman) 05/27/2020

Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman) In this Medicine Matters oncology podcast, we speak to Gary Lyman (Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, USA) about the impact of the COVID-19 outbreak on the conduct of cancer clinical trials. /episode/index/show/oncologymedicinematters/id/14586986

The UK Coronavirus Cancer Monitoring Project: What you need to know (with Lennard Lee) 05/22/2020

The UK Coronavirus Cancer Monitoring Project: What you need to know (with Lennard Lee) Co-project leader Lennard Lee talks about the inception and development of the initiative that will provide insight into the impact of COVID-19 on people with cancer and facilitate shared learning that will benefit patient care. /episode/index/show/oncologymedicinematters/id/14526080

CCC19: Introducing The COVID-19 and Cancer Consortium (with Gilberto Lopes) 04/08/2020

CCC19: Introducing The COVID-19 and Cancer Consortium (with Gilberto Lopes) Gilberto Lopes (Sylvester Comprehensive Cancer Center at the University of Miami, Florida, USA), a steering committee member of CCC19, tells us about the registry collating data on cancer patients with comorbid COVID-19 to provide an evidence base for future decision-making. /episode/index/show/oncologymedicinematters/id/13902305

COVID-19 and cancer: Changing practices to meet patient needs (with Beth Sandy) 03/31/2020

COVID-19 and cancer: Changing practices to meet patient needs (with Beth Sandy) Thoracic oncology nurse practitioner Beth Sandy explains how the coronavirus pandemic is affecting cancer patient care and how strategies such as telemedicine are coming into their own. /episode/index/show/oncologymedicinematters/id/13777346

Managing patients with genitourinary cancers in the time of COVID-19 (with Cora Sternberg) 03/25/2020

Managing patients with genitourinary cancers in the time of COVID-19 (with Cora Sternberg) Genitourinary oncologists Cora Sternberg (Weill Cornell Medicine, New York, USA) and Axel Merseburger (University Hospital Schleswig-Holstein, Lübeck, Germany) share their experience of managing cancer patients during the COVID-19 pandemic, comparing perspectives from a US and German stand point. /episode/index/show/oncologymedicinematters/id/13693649

COVID-19 and cancer patient care: A lung cancer specialist’s experience (with Gilberto Lopes) 03/17/2020

COVID-19 and cancer patient care: A lung cancer specialist’s experience (with Gilberto Lopes) Gilberto Lopes discusses the impact of the COVID-19 pandemic on the management of patients with lung cancer and outlines the measures being implemented to minimize the risk for patients. /episode/index/show/oncologymedicinematters/id/13584320

Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay) 10/07/2019

Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay) Colin Lindsay discusses the trial results for AMG 510 – a novel inhibitor targeting the KRAS G12C mutation – in patients with locally advanced or metastatic non-small-cell lung cancer. /episode/index/show/oncologymedicinematters/id/11542229

Understanding the relationship between the gut microbiome and immunotherapy (with Jennifer Wargo) 06/24/2019

Understanding the relationship between the gut microbiome and immunotherapy (with Jennifer Wargo) Recent research has shown an association between intestinal microbiota and response to immunotherapy in the setting of various tumor types. Listen to Jennifer Wargo, from The University of Texas MD Anderson Cancer Center in Houston, USA, share her insights into the findings. /episode/index/show/oncologymedicinematters/id/10268072

Researcher comment: COMPARE study (with Hashim Ahmed) 06/24/2019

Researcher comment: COMPARE study (with Hashim Ahmed) Hashim Ahmed takes us through the COMPARE study which showed that men with localized prostate cancer are willing to accept lower survival odds for a better quality of life. He outlines the key findings, the implications of the results for physicians, and the next steps for research. /episode/index/show/oncologymedicinematters/id/10267979

ALL and infection: Unpicking the connection (with Mel Greaves) 06/24/2019

ALL and infection: Unpicking the connection (with Mel Greaves) Professor Mel Greaves (Institute of Cancer Research, London, UK) discusses his proposed theory for the etiology of childhood acute lymphoblastic leukemia, in which early microbial exposure plays a key role. He outlines the evidence supporting the hypothesis and delves into the implications. /episode/index/show/oncologymedicinematters/id/10267898

SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan) 06/24/2019

SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan) Advisory Board member and study author Paul Nathan, from the Mount Vernon Cancer Centre in Middlesex, UK, discusses the phase III SUMIT trial, which evaluated the addition of the MEK inhibitor selumetinib to dacarbazine in patients with metastatic uveal melanoma. /episode/index/show/oncologymedicinematters/id/10267766

Expert comment: AMPLE trial (with Fabien Maldonado) 06/24/2019

Expert comment: AMPLE trial (with Fabien Maldonado) Fabien Maldonado, from Vanderbilt UMC in Nashville, Tennessee, USA, provides an independent comment on the AMPLE trial, published in JAMA, which aimed to establish the more effective technique for reducing the number of hospitalization days in patients with malignant pleural effusion. /episode/index/show/oncologymedicinematters/id/10267682

Bevacizumab in cervical cancer (with Krishnansu Tewari) 06/24/2019

Bevacizumab in cervical cancer (with Krishnansu Tewari) The phase III GOG 240 trial evaluated bevacizumab in women with advanced cervical cancer - Advisory Board member and lead investigator Krishnansu Tewari outlines the results of the final analysis in this podcast. /episode/index/show/oncologymedicinematters/id/10264442

Medicine Matters oncology

TOPICS